Voloridge Investment Management, LLC Ngm Biopharmaceuticals Inc Transaction History

Voloridge Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $201,059 - $270,797	-14,559 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$17.26 - $22.02 $251,288 - $320,589	14,559 New	14,559 $258,000
Q4 2020 Feb 16, 2021	SELL	$16.21 - $31.44 $167,416 - $324,712	-10,328 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$15.59 - $19.97 $191,211 - $244,932	-12,265 Reduced 54.29%	10,328 $164,000
Q2 2020 Aug 14, 2020	BUY	$11.97 - $23.47 $270,438 - $530,257	22,593 New	22,593 $446,000
Q1 2020 May 15, 2020	SELL	$10.0 - $19.51 $111,660 - $217,848	-11,166 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$9.97 - $20.28 $111,325 - $226,446	11,166 New	11,166 $206,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.